Close
Get alerts of updates about «Tapering for pregnant women in opioid maintenance treatment (OMT)»
You have subscribed to alerts about:
- Tapering for pregnant women in opioid maintenance treatment (OMT)
Oops, something went wrong...
... contact nettredaksjon@fhi.no.
... reload the page and try again-
Project
Tapering from buprenorphine or methadone for pregnant women in opioid maintenance treatment (OMT) - project description
Published
Norwegian Institute of Public Health has been commissioned by the Norwegian Directorate of Health to carry out a systematic review of effects of methadone or buprenorphine tapering during pregnancy.
Summary
Norwegian experts disagree in the question of whether women who become pregnant during opioid maintenance treatment (OMT), should have their OMT drug (methadone or buprenorphine) tapered, or whether they should continue maintenance treatment. We will systematically summarise research of effects for mother and child of tapering compared to continued maintenance treatment during pregnancy.